AMPINAX

Ampicillin is a semi-synthetic derivative of penicillin that functions as an Oral active broad-spectrum antibiotic.

For treatment of infection (Respiratory, GI, UTI and meningitis) due to E. coli, P. mirabilis, enterococci, Shigella, S. typhosa and other Salmonella, nonpenicillinase-producing N. gononhoeae, H. influenzae, staphylococci, streptococci including streptoc

Ampicillin is a penicillin beta-lactam antibiotic used in the treatment of bacterial infections caused by susceptible, usually gram-positive, organisms.

The name "penicillin" can either refer to several variants of penicillin available, or to the group of antibiotics derived from the penicillins.

Ampicillin has in vitro activity against gram-positive and gram-negative aerobic and anaerobic bacteria.

The bactericidal activity of

Ampicillin results from the inhibition of cell wall synthesis and is mediated through Ampicillin binding to penicillin binding proteins (PBPs).

Ampicillin is stable against hydrolysis by a variety of beta-lactamases, including penicillinases, and cephalosporinases and extended spectrum beta-lactamases.

Penicillin-binding protein 2a (Streptococcus pneumoniae (strain ATCC BAA-255 / R6)) Inhibitor Penicillin-binding protein 1b (Streptococcus pneumoniae (strain ATCC BAA-255 / R6)) Inhibitor serine-type D-Ala-D-Ala carboxypeptidase (Streptococcus pneumoniae) Inhibitor + 2 more targets.

Ampicillin is excreted largely unchanged in the urine.

Improve decision support & research outcomes With structured adverse effects data, including: blackbox warnings, adverse reactions, warning & precautions, & incidence rates.

View sample adverse effects data in our new Data Library! See the data Improve decision support & research outcomes with our structured adverse effects data.